Business Wire

Talkdesk Enters Next Decade Fueled by Innovation, Expanded International Presence, New Brand

27.4.2021 18:30:00 EEST | Business Wire | Press release

Share

Talkdesk®, Inc., the global customer experience leader for customer-obsessed companies, today embarked on the next phase of growth after two years of significant momentum in executing toward its bold vision to provide a better way for organizations to unlock the promise and potential of great customer service. To mark this new stage in its corporate maturation, Talkdesk unveiled a new logo and tagline – Experience. A better way. – that reflects the company’s commitment to being at the forefront of customer experience (CX) innovation and its focus on empowering customers to build brand trust and loyalty through customized, personal interactions.

Talkdesk’s reimagined logo reflects its commitment to helping companies connect every engagement moment into customer journeys that are personalized, productive and profitable. The bold new corporate identity comprises a fresh purple color palette and updated brand elements, featuring inclusive and diverse visual representations and illustrations that reflect the importance of human connection. The company also relaunched its website in five new languages – Brazilian Portuguese, French, German, Portuguese and Spanish, and unveiled a powerful new international advertising campaign.

“Today is about retelling the Talkdesk story in a way that pays tribute to our legacy, embraces our commitment to diversity and giving back, and deeply connects our path forward to the thousands of Talkdesk customers and employees who made what is yet to come possible,” said Kathie Johnson, chief marketing officer, Talkdesk. “Every element of who we are represents the importance of the connection we help companies make with their customers, because every moment matters.”

Talkdesk today also introduced availability of two additions to Talkdesk CX Cloud™ designed to propel the company into its new wave of growth: Talkdesk Workspace, a customizable user interface, and Talkdesk Builder, a set of tools for unlimited and accelerated contact center customization across workspaces, routing, reporting and integrations. Since its inception, rapid innovation has been a Talkdesk hallmark – one applauded by both customers and industry leaders, and valued by enterprise customers worldwide.

“Ten years ago, Talkdesk founder Tiago Paiva saw how Salesforce had re-invented the CRM world and realized a similar revolution was imminent for the call center,” said Sheila McGee-Smith, founder and principal analyst, McGee-Smith Analytics, LLC. “Talkdesk has been a significant part of the industry-wide contact center transformation, helping to move the industry toward a true elastic cloud, with all the innovation power that brings for not just customers but the entire customer experience ecosystem.”

Over the past 24 months, Talkdesk achieved several significant milestones, including:

  • An international expansion that extended the company’s footprint not only within Portugal, the United Kingdom and the United States, but also into Australia, Brazil, France, Germany, Ireland, Italy, the Netherlands, Southeast Asia and Spain
  • A proven executive leadership team – which is 45% female – with experience at some of the technology industry’s leading companies, including AT&T, Cloudera, Oracle, Salesforce and SAP
  • Bringing to market 20 innovations in the first 20 weeks of 2020, including solutions designed to help its customers through the pandemic
  • Expansion and strengthening of its partner ecosystem of cloud distributors, resellers, marketplace and strategic alliance partners
  • Launching industry specific solutions to help address the unique customer service challenges of financial services and insurance, healthcare and life sciences, retail and e-commerce, and travel and hospitality companies
  • Raising Series C funding of $143 million, bringing the company’s valuation to more than $3 billion
  • Positioned as a leader in the 2020 Gartner Cloud Contact Center as a Service (CCaaS) Magic Quadrant
  • Positioned as a leader in the 2020 Forrester Wave for CCaaS

“Today marks an inflection point in Talkdesk history. Talkdesk was founded on the principle that there had to be a better way for companies to deliver exceptional customer service. We now have customers in every major region of the world who have transformed their end-customers’ experience into an immersive, personalized and profitable journey,” said Tiago Paiva, Talkdesk founder and chief executive officer. “Our cloud-native platform was one of many industry-firsts Talkdesk introduced to the contact center marketplace over its first decade, and our talented

development team is hard at work on the products that will define our next 10 years of audacious innovation.”

Additional Resources

  • Read Kathie Johnson’s perspective on leading Talkdesk through transformation growth as the company’s first chief marketing officer
  • Read the press release introducing Talkdesk Workspace, a customizable interface designed to enable a better way to deliver superior customer experiences in contact centers
  • Learn more about the new Talkdesk brand

Social Networks

About Talkdesk

Talkdesk® is a global customer experience leader for customer-obsessed companies. Our contact center solution provides a better way for businesses and customers to engage with one another. Our speed of innovation and global footprint reflect our commitment to ensure businesses everywhere can deliver better customer experiences through any channel, resulting in higher customer satisfaction, cost savings and profitability. Talkdesk CX CloudTM is an end-to-end customer experience solution that combines enterprise scale with consumer simplicity. Over 1,800 innovative companies around the world, including IBM, Acxiom, Trivago, and Fujitsu partner with Talkdesk to deliver a better way to great customer experience. Learn more and request a demo at www.talkdesk.com.

Talkdesk is a registered trademark of Talkdesk, Inc. All product and company names are trademarks ™ or registered ® trademarks of their respective holders. Use of the does not imply any affiliation or endorsement by them.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Contacts:
Americas
Camille Beasley
camille.beasley@talkdesk.com
(972) 896-1936

EMEA
Douglas Keighley
douglas.keighley@talkdesk.com
+44 7830144613

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 08:00:00 EEST | Press release

Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufacturing site. All other aspects of the BLA, including safety- and efficacy-related parts, did not solicit deficiencies to be addressed. The FDA made observations during the PLI for which Galderma is putting in place corrective and preventive actions. Galderma will also be seeking further guidance through continued open dialogue with the FDA toward resolution of the relevant observations. Galderma plans to rapidly respond to the CRL and advancing RelabotulinumtoxinA in the U.S. remains a top priority. The ob

EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 04:45:00 EEST | Press release

EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia

Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 02:56:00 EEST | Press release

Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release

Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye